BUCGX
Price
$18.99
Change
+$0.16 (+0.85%)
Updated
Jun 6 closing price
Net Assets
387.88M
BUYGX
Price
$20.59
Change
+$0.16 (+0.78%)
Updated
Jun 6 closing price
Net Assets
387.88M
Interact to see
Advertisement

BUCGX vs BUYGX

Header iconBUCGX vs BUYGX Comparison
Open Charts BUCGX vs BUYGXBanner chart's image
Vest US Large Cap 10% Buffer Strats C
Price$18.99
Change+$0.16 (+0.85%)
VolumeN/A
Net Assets387.88M
Vest US Large Cap 10% Buffer Strats Y
Price$20.59
Change+$0.16 (+0.78%)
VolumeN/A
Net Assets387.88M
BUCGX vs BUYGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BUCGX vs. BUYGX commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BUCGX is a Hold and BUYGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BUCGX (388M) and BUYGX (388M) have equal amount of cash in the bank . BUCGX (0.00) and BUYGX (0.00) have matching dividends . BUCGX was incepted earlier than BUYGX: BUCGX (7 years) vs BUYGX (7 years). BUCGX (2.10) is less costly to investors than BUYGX (0.95). BUCGX (54.65) and BUYGX (54.65) have comparable annual turnover. BUCGX has a lower initial minimum investment than BUYGX: BUCGX (1000) vs BUYGX (10000000). BUYGX annual gain was more profitable for investors over the last year : 7.47 vs. BUCGX (6.14). BUYGX return over 5 years is better than : 56.48 vs. BUCGX (46.99).
BUCGXBUYGXBUCGX / BUYGX
Total Expense Ratio1.950.70279%
Annual Report Gross Expense Ratio2.100.95221%
Fund Existence7 years7 years-
Gain YTD0.0000.591-
Front LoadN/AN/A-
Min. Initial Investment1000100000000%
Min. Initial Investment IRAN/AN/A-
Net Assets388M388M100%
Annual Yield % from dividends0.000.00-
Returns for 1 year6.147.4782%
Returns for 3 years29.8634.8586%
Returns for 5 years46.9956.4883%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNSP1.040.03
+2.97%
CNS Pharmaceuticals Inc.
XIFR8.910.25
+2.89%
XPLR Infrastructure LP
INSM73.620.88
+1.21%
Insmed
IKT1.96N/A
N/A
Inhibikase Therapeutics
TK8.61-0.11
-1.26%
Teekay Corporation Ltd